ACTRN12612000087853招募中未知
Patient outcome after reversal of residual neuromuscular blockade with either neostigmine or no reversal agent vs. reversal with sugammadex.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Patients operated at Royal Perth Hospital and tracheally intubated with the use of a neuromuscular blocking agent. Hereby the reason for the operation (= original medical condition leading to treatment) is unimportant
排除标准
- •Patients with significant multi-trauma, cardiothoracic surgery and patients who arrive in or leave theatres intubated
研究者
相似试验
已完成
不适用
Clinical and radiological outcoume following reverse shoulder arthroplasty in fracturesOutcome of reverse shoulder arthroplasty after fracturesDRKS00026227BG Unfallklinik Tübingen62
尚未招募
Unknown
A study to assess inadequate neuromuscular recovery in postoperative period immediately on arrival and after 30 minutes of arrival by measuring Train of Four ratios after use of intermediate muscle relaxant intraoperativelyCTRI/2023/09/057759Max Superspeciality Hospital
已完成
不适用
The outcome and prognosis of neurological decompression and stabilization for spinal metastasisspinal metastasisJPRN-UMIN000029381Department of Orthopaedic Surgery Yokosuka Kyosai Hospital30
已完成
不适用
ong-term clinical outcome after reconstruction of atrophied alveolar ridge using collagenated xenogeneic bone block (CXBB) or autogenous bone block (ABB). Follow-up of randomized controlled clinical investigation 10828-021.Survival of the implants as well as the bone tissue and soft tissue at the augmented areaDRKS00017137Geistlich Pharma AG51
已完成
1 期
Outcomes of care for patients with residual symptoms of COVID-19 infection with lifestyle medicine and integrative medicinePost COVID-19 syndromeCOVID-19, integrative medicine, post-COVID syndrome, lifestyle medicineTCTR20230314001Chao Phya Abhaibhubejhr hospital foundation20